Achyut Healthcare LtdBOM 543499 Stock Report

Achyut Healthcare Ltd. engages in the trading of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. The company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The firm is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The firm is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.